med spa with tirzepatide The rumors are true… GLP-1s aren't just about weight loss. 👀 Many patients are now exploring microdosing as part of a broader wellness approach — supporting metabolic health, blood sugar balance The SD Med Spa is

2016;45(4 Suppl):S18-21

Patients with a body mass index BMI of 30 or more, or a BMI of 27 with related conditions, will receive 2.4 mg injections once per week

In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting

They are usually sold as transdermal patches

In this context, our findings suggest that devising treatment algorithms combining MBS and pharmacotherapy can lead to more effective and patient-centered long-term treatment strategies for severe obesity